Open AccessSecukinumab's Pooled and Long-Term Safety: Analysis of 19 Psoriasis Clinical Trials Up to 5 Years of Treatment
Author(s) -
PCM van de Kerkhof,
Kristian Reich,
C Leonardi,
Andrew Blauvelt,
NN Mehta,
TF Tsai,
R. You,
Phil Papanastasiou,
M. Milutinovic,
C.E.M. Griffiths
Publication year - 2018
Publication title -
skin the journal of cutaneous medicine
Language(s) - English
Resource type - Journals
ISSN - 2574-1624
DOI - 10.25251/skin.2.supp.18
Subject(s) - secukinumab , medicine , term (time) , psoriasis , clinical trial , safety profile , pooled analysis , dermatology , meta analysis , adverse effect , psoriatic arthritis , physics , quantum mechanics
not available. Disclosures: Study sponsored by Novartis. Copyright 2018 SKIN
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom